METHOD OF MANUFACTURING DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET AND DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET MANUFACTURED USING THE SAME

LEPTIN THERAPY FOR GLUCOSE METABOLISM DISORDERS

METHODS FOR TREATING MOOD DISORDERS BY ADMINISTERING A LEPTIN RECEPTOR AGONIST

METHODS OF TREATMENT USING A LEPTIN RECEPTOR AGONIST ANTIBODY

METHODS AND MATERIALS FOR TREATING OBESITY

GLP-1R MODULATING COMPOUNDS

PRODUCTION OF ENHANCED STEM CELL-BASED EXOSOMES AND USES IN SCAR TISSUE PREVENTION AND TREATMENT

MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF

COMPOUNDS FOR THE TREATMENT OF OBESITY AND METHODS OF USE THEREOF

PRODUCTION OF ENHANCED STEM CELL-BASED EXOSOMES AND USES IN SCAR TISSUE PREVENTION AND TREATMENT

ORAL ALGAL OIL BASED GASTRO-INTESTINAL TRACT PERMEABLE PEPTIDE COMPOSITION

COMPOSITIONS AND METHODS FOR ACTIVATING A NEURAL RECEPTOR

Pancreatic Islets as Protein Factories

THERAPEUTIC AGENTS AND USES THEREOF

EFFICIENT AQUEOUS ENCAPSULATION AND CONTROLLED RELEASE OF BIOACTIVE AGENTS

Butyrylcholinesterases having an enhanced ability to hydrolyze acyl ghrelin

METHODS FOR TREATING ANOREXIA NERVOSA AND RELATED CONDITIONS BY ADMINISTERING A LEPTIN RECEPTOR AGONIST

FUSOKINES INVOLVING CYTOKINES WITH STRONGLY REDUCED RECEPTOR BINDING AFFINITIES

GLP-1R MODULATING COMPOUNDS

COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF HYPOGLYCEMIC COMPLICATIONS

METHODS OF TREATMENT USING A LEPTIN RECEPTOR AGONIST ANTIBODY

INTRANASAL LEPTIN COMPOSITIONS AND METHODS OF USE THEREOF FOR PREVENTION OF OPIOID INDUCED RESPIRATORY DEPRESSION IN OBESITY

TARGETING BIOLOGICAL AGENTS TO MUCOSAL DEFECTS OF THE GASTROINTESTINAL TRACT

Glucagon derivative and a composition comprising a long acting conjugate of the same

MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF

METHOD OF MANUFACTURING DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET AND DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET MANUFACTURED USING THE SAME

Compounds for the treatment of obesity and methods of use thereof

IMPROVED WEIGHT LOSS THERAPY

Method of Delivering a Centrally-Acting Peptide Derivative, and Method of Treating a Neuropsychiatric Disorder

Methods for Improving Leptin Sensitivity for the Treatment of Obesity and Diabetes

Use of CD24 Proteins for Treating Leptin-Deficient Conditions

Compounds for the treatment of obesity and methods of use thereof

Engineered polypeptides having enhanced duration of action

METHODS FOR TREATING PSORIASIS

USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT

Glucagon derivative and a composition comprising a long acting conjugate of the same

Therapeutic targeting of SET1B/compass pathway for treating cancers

TREATMENT OF OBESITY AND EATING DISORDERS

Methods of treating a neurological or psychiatric disorder

METHODS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS WITH ENHANCED PHARMACOLOGICAL PROPERTIES

Efficient aqueous encapsulation and controlled release of bioactive agents

Lipids and lipid compositions for the delivery of active agents

Methods for treating psoriasis

Modified therapeutic agents and compositions thereof

USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT

Butyrylcholinesterases having an enhanced ability to hydrolyze acyl ghrelin

Peptide with anti-obesity and anti-diabetes activity and use thereof

Peptide with anti-obesity and anti-diabetes activity and use thereof

Peptide with anti-obesity and anti-diabetes activity and use thereof

NURR1 activation in the treatment of metabolic disorders and as an exercise mimetic

METHODS AND COMPOSITIONS RELATING TO LEPTIN ANTAGONISTS

COMPOUNDS FOR THE TREATMENT OF OBESITY AND METHODS OF USE THEREOF

Treatment of ischemia and reperfusion using leptin antagonist

Use of CD24 proteins for treating leptin-deficient conditions

Drug eluting stent

MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF

Lipids and lipid compositions for the delivery of active agents

PROTEIN CONJUGATE USING A FATTY ACID DERIVATIVE AND METHOD FOR PREPARATION THEREOF

METHODS AND COMPOSITIONS USING AMPK ACTIVATORS FOR PHARMACOLOGICAL PREVENTION OF CHRONIC PAIN

Engineered Polypeptides Having Enhanced Duration of Action and Reduced Immunogenicity

Devices, formulations, and methods for delivery of multiple beneficial agents

COMPOUNDS FOR THE TREATMENT OF OBESITY AND METHODS OF USE THEREOF

Glucagon derivative and a composition comprising a long acting conjugate of the same

Exendin-4 derivatives as dual GLP1/glucagon agonists

Compounds for the treatment of obesity and methods of use thereof

Peptide with anti-obesity and anti-diabetes activity and use thereof

Leptin active peptide having cd loop and E helix region mutations, coding gene thereof, and application thereof

Leptin active peptide having D helix region mutations, coding gene thereof, and application thereof

METHODS FOR TREATING MELANOMA

SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF

Therapeutic targeting of SET1B/compass pathway for treating cancers

Method of highly expressing target protein from plant using RbcS fusion protein and method of preparing composition for oral administration of medical protein using target protein expression plant body

Myristoylated leptin-related peptides and uses thereof

Compounds for the treatment of obesity and methods of use thereof

Functionalized Exendin-4 derivatives

USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD FOR DETERMINING PREDISPOSITION TO SAID TREATMENT

DEVICES, FORMULATIONS, AND METHODS FOR DELIVERY OF MULTIPLE BENEFICIAL AGENTS

COMPOUNDS FOR THE TREATMENT OF OBESITY AND METHODS OF USE THEREOF

LEPTIN mRNA COMPOSITIONS AND FORMULATIONS

Pharmaceutical microemulsion immobilized in a thin polymer matrix and methods of making them

Lipids and lipid compositions for the delivery of active agents

Modified therapeutic agents and compositions thereof

Methods and compositions relating to leptin antagonists

PEPTIDE THERAPEUTIC CONJUGATES AND USES THEREOF

Composition-of-matter and method for treating cardiovascular disorders

Engineered polypeptides having enhanced duration of action and reduced immunogenicity

Methods and compositions for delivering active agents with enhanced pharmacological properties

Lipids and lipid compositions for the delivery of active agents

Novel Peptides Involved in Energy Homeostasis

Chimeric leptin polypeptide and method of using the same

Methods And Compositions For Preventing Or Treating Obesity

LEPTIN FOR TREATING SYSTEMIC INFLAMMATORY RESPONSE SYNDROME

Particles containing a growth factor, and uses thereof

Compositions and methods for treating cognitive deficits

Designer circuit controlling diet-induced obesity

Method of treating obesity in a companion animal comprising administering a modified canine leptin polypeptide

METHOD FOR INTRODUCING BIOLOGICALLY ACTIVE SUBSTANCES INTO THE BRAIN

DELIVERY OF BIOTHERAPEUTICS TO THE BRAIN

COMPOUNDS FOR THE TREATMENT OF OBESITY AND METHODS OF USE THEREOF

METHOD FOR TREATING OBESITY WITH ANTI-OBESITY FORMULATIONS AND OMEGA 3 FATTY ACIDS FOR THE REDUCTION OF BODY WEIGHT IN CARDIOVASCULAR DISEASE PATIENTS (CVD) AND DIABETICS

Compounds for the treatment of obesity and methods of use thereof

Efficient aqueous encapsulation and controlled release of bioactive agents

Oral Leptin Formulations and Uses Thereof

Methods for modulating Th1/Th2 cell balance by increasing leptin activity

Therapeutic use of activators of zinc finger protein GL13

GEL COMPOSITIONS

Dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonists

Functionalized exendin-4 derivatives

METHODS FOR TREATING PROGRESSIVE COGNITIVE DISORDERS RELATED TO NEUROFIBRILLARY TANGLES

Exendin-4 derivatives as dual GLP1/glucagon agonists

Leptin Rescues Neurons from Alzheimer's Disease Related Pathways Triggered by Lipid Burden

Methods for preventing or treating eye diseases using adiponectin

LEPTIN DERIVATIVES

Particles containing a growth factor, and uses thereof

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OBESITY

Method for controlling post-operative sepsis infection by administering adiponectin

Novel Peptide Involved in Energy Homeostasis

Therapeutic application of adiponectin in patients with ventricular fibrillation

Compositions and methods for treating cognitive deficits

Use of Leptin for Treating Human Lipoatrophy and Method of Determining Predisposition to Said Treatment

Fragments, Mutants and Chimeric Fusion Proteins of Leptin For Treating Alzheimer's Disease

Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin

High affinity leptins and leptin antagonists

GPR 119 MODULATORS

Compositions and Methods for Delaying Senescence or Cell Death in Neurons

EXENDIN AND EXENDIN AGONISTS FOR EATING DISORDERS

LEPTIN FOR USE IN INCREASING LIVER REGENERATION

Therapeutic agent for accelerating recovery of animal under medical treatment

METHODS FOR MODULATING CIRCADIAN RHYTHMS

METHODS FOR MODULATING METABOLIC AND CIRCADIAN RHYTHMS

METHODS FOR TREATING TYPE I DIABETES WITH LEPTIN AND LEPTIN AGONISTS

AMYLIN AGONIST COMPOUNDS FOR ESTROGEN-DEFICIENT MAMMALS

Therapeutic Application of Adiponectin in Patients with Acute Myocardial Infarction

Methods for treating progressive cognitive disorders related to neurofibrillary tangles

Use of leptin to treat metabolic abnormalities associated with lipoatrophy

Adiponectin receptor fragments and methods of use

PEPTIDE THERAPEUTIC CONJUGATES AND USES THEREOF

Methods for decreasing leptin levels or activity for treating inflammation

ADIPONECTIN FOR TREATING PULMONARY DISEASE

Method of treating fatty liver diseases and conditions in non-lipodystrophic subjects

Leptin peptide antagonists

Methods and compositions for the treatment of obesity

METHODS OF INCREASING BONE FORMATION USING LEPTIN-RELATED PEPTIDES

System for Curing Hepatic Cancer with Leptin

INSULIN RESISTANCE IMPROVING AGENT

COMPOSITIONS FOR ENTERAL ABSORPTION AND SUSTAINED ACTION OF LEPTIN-RELATED PEPTIDES USEFUL IN THE TREATMENT OF OBESITY AND LEPTIN-MODULATED DISEASE

ENCAPSULATED PANCREATIC ISLET CELL PRODUCTS AND METHODS OF USE THEREOF

REGULATORY T CELLS IN ADIPOSE TISSUE

Exendin and exendin agonists for eating disorders

Method and compositions for prevention and treatment of diabetic and aged skin

METHODS FOR TREATING OBESITY AND OBESITY RELATED DISEASES AND DISORDERS

Methods to treat symptoms of pathophysiology related to body mass

METHODS, COMPOSITIONS AND TRANSGENIC MODELS RELATED TO THE INTERACTION OF T-CADHERIN AND ADIPONECTIN

USE OF LEPTIN IN THE PREVENTION OF UNHEALTHY FOOD HABITS AND CARDIOVASCULAR DISEASES

Treating alzheimer's disease and osteoporosis and reducing aging

USE OF LEPTIN FOR THE PREVENTION OF EXCESS BODY WEIGHT AND COMPOSITION CONTAINING LEPTIN

Insulin resistance improving agents

Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amyloid beta

Dynamic nerve stimulation in combination with other eating disorder treatment modalities

ADIPONECTIN FOR THE TREATMENT AND DIAGNOSIS OF ALBUMINURIA

METHODS FOR TREATING PROGRESSIVE COGNITIVE DISORDERS RELATED TO NEUROFIBRILLARY TANGLES

USE OF THE GLOBULAR DOMAIN OF ACRP30 FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION AND/OR TREATMENT OF THROMBOSIS-RELATED DISEASES

Methods of inhibiting seizure in a subject

Novel peptide involved in energy homeostasis

PREVENTIVE/REMEDY FOR ARTERIOSCLEROSIS

ISOLATED STROMAL CELLS FOR USE IN THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM

Devices, formulations, and methods for delivery of multiple beneficial agents

Adiponectin for treatment of various disorders

Exendin agonist analogs to treat diabetes

Derivatives of GLP-1 analogs

Compounds for improving nutritional status, cognition and survival

Phosphodiesterase 10 Inhibition as Treatment for Obesity-Related and Metabolic Syndrome-Related Conditions

Methods for treating obesity and obesity related diseases and disorders

Adiponectin receptor fragments and methods of use

Method of reducing or inhibiting ObR signaling using a leptin antagonist consisting of SEQ id No: 2

ADMINISTRATION OF ADIPOCYTOKINE AND ADIPONECTIN FOR TREATING HEADACHE AND METHODS OF DIAGNOSING HEADACHE BY MEASURING ADIPONECTIN

Use of ACRP30 Globular Head to Promote Increases in Muscle Mass and Muscle Differentiation

DYNAMIC NERVE STIMULATION IN COMBINATION WITH OTHER EATING DISORDER TREATMENT MODALITIES

Compositions containing leptin

Inhibition of wet type age related macular degeneration (AMD) by adiponectin or acrp 30

Methods of treating obesity with two different anti-obesity agents

Use of Leptin for the Prevention of Excess Body Weight and Composition Containing Leptin

Method For Control of Invasion and Use of Adiponectin

Leptin-related peptides

Compositions and methods for polynucleotide delivery

Use of Leptin in Wound Healing

Methods of increasing lean tissue mass using OB protein compositions

Methods And Compositions Using Adiponectin For Treatment Of Cardiac Disorders And For Stimulation Of Angiogenesis

Use of adiponectin to diagnose and treat malignancy

Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment

OB fusion protein compositions and methods

Adiponectin variants

Methods and compositions for modulating the interaction between adiponectin and its receptor

Pharmaceutical compositions of adiponectin variants and methods of storage

Method of treatment using adiponectin variants

Anti-tumor agent

Derivatives of GLP-1 analogs

Insulin resistance improving agent

Method for treating arteriosclerosis

Liver regeneration promoting agent

Use of exendins and agonists thereof to treat diabetes

Method for treating respiratory distress syndrome

Methods and uses of leptin in immune modulation

Methods and uses of leptin in hepatocellular carcinoma

Method of treating, preventing, and diagnosing prostate cancer

Use of Acrp30 globular head to promote increases in muscle mass and muscle differentiation

Anti-osteolytic therapy involving adiponectin

Enhanced adipose tissue

OBG3 Fragments Inhibiting The Conversion Of Active OBG3 Into Less Active OBG3 And Other Compositions For Treatment Of Metabolic Disorders

Method for enhancing proliferation or differentiation of a cell using OB protein

Leptin peptide antagonists

Pharmaceutical compositions containing exendins

Methods of increasing lean tissue mass using OB protein compositions

OB fusion protein compositions and methods

Methods for using the obese gene and its gene product to identify hematopoietic progenitor cells

Single-dose taste inhibitor units

Use of exendins and agonists thereof for lowering plasma lipid

Use of obg3 for promoting central nervous system remyelination

Use of leptin in fertility

Use of leptin for infant with low birth weight for prevention of obesity

Exendins, exendin agonists, and methods for their use

Use of adiponectin to diagnose and treat malignancy

Leptin-related peptides

Exendins and exendin agonists for weight reduction and obesity

Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment

Methods and compositions using AMPK activators for pharmacological prevention of chronic pain